Evidence map›Paper›PMID 34403563›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2021

Kidney allograft biopsy findings after COVID-19.

Emily Daniel, Miroslav Sekulic, Satoru Kudose, Christine Kubin, Xiaoyi Ye, Katayoon Shayan, Ankita Patel, David J Cohen, Lloyd E Ratner, Dominick Santoriello and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. COVID-19 and Glomerular Diseases.Kidney international reports · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Virus-Associated Nephropathies: A Narrative Review.International journal of molecular sciences · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Emily DanielDepartment of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0002-5690-4661
Miroslav SekulicDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0002-7938-1816
Satoru KudoseDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0001-8396-9877
Christine KubinDepartment of Pharmacy, New York Presbyterian Hospital, New York, New York, USA.
Xiaoyi YeDepartment of Medicine, Nephrology, Hartford Hospital, Hartford, Connecticut, USA.ORCID 0000-0001-5685-7239
Katayoon ShayanDepartment of Pathology, Rady Children's Specialists of San Diego, California, USA.
Ankita PatelDepartment of Medicine, Nephrology, Hackensack University Medical Center, Hackensack, New Jersey, USA.ORCID 0000-0001-5084-2490
David J CohenDepartment of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0003-1227-3252
Lloyd E RatnerDepartment of Surgery, Renal and Pancreatic Transplantation, Columbia University Irving Medical Center, New York, New York, USA.
Dominick SantorielloDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0001-5854-4236
M Barry StokesDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0003-0958-7672
Glen S MarkowitzDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
Marcus R PereiraDepartment of Medicine, Division of Infectious Disease, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0002-9214-9122
Vivette D D'AgatiDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
Ibrahim BatalDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0002-0686-5457
Columbia University Irving Medical Center · USHackensack University Medical Center · USHartford Hospital · USNewYork–Presbyterian Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 has been associated with acute kidney injury and published reports of native kidney biopsies have reported diverse pathologies. Case series directed specifically to kidney allograft biopsy findings in the setting of COVID-19 are lacking. We evaluated 18 kidney transplant recipients who were infected with SARS-CoV-2 and underwent allograft biopsy. Patients had a median age of 55 years, six were female, and five were Black. Fifteen patients developed COVID-19 pneumonia, of which five required mechanical ventilation. Notably, five of 11 (45%) biopsies obtained within 1 month of positive SARS-CoV-2 PCR showed acute rejection (four with arteritis, three of which were not associated with reduced immunosuppression). The remaining six biopsies revealed podocytopathy (n = 2, collapsing glomerulopathy and lupus podocytopathy), acute tubular injury (n = 2), infarction (n = 1), and transplant glomerulopathy (n = 1). Biopsies performed >1 month after positive SARS-CoV-2 PCR revealed collapsing glomerulopathy (n = 1), acute tubular injury (n = 1), and nonspecific histologic findings (n = 5). No direct viral infection of the kidney allograft was detected by immunohistochemistry, in situ hybridization, or electron microscopy. On follow-up, two patients died and most patients showed persistent allograft dysfunction. In conclusion, we demonstrate diverse causes of kidney allograft dysfunction after COVID-19, the most common being acute rejection with arteritis.

Indexed as

Acute Kidney InjuryCOVID-19AllograftsBiopsyFemaleGraft RejectionHumansKidneyMiddle AgedSARS-CoV-2biopsyclinical research / practicecomplication: infectiousinfection and infectious agents - viralkidney (allograft) function / dysfunctionkidney transplantation / nephrology

Identifiers

PMID34403563
PMCPMC8441660
OpenAlexW3193725929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.